Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.
about
Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccineParticipation of the serine-rich Entamoeba histolytica protein in amebic phagocytosis of apoptotic host cells.Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal deliveryCharacterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation systemIn-silico prediction and modeling of the Entamoeba histolytica proteins: Serine-rich Entamoeba histolytica protein and 29 kDa Cysteine-rich protease.Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice.Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea PigsGonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in miceExploiting cholera vaccines as a versatile antigen delivery platformThe future for vaccine development against Entamoeba histolytica.Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.
P2860
Q30407857-C6214DD3-FD91-4C14-BB0C-F7D7329C528BQ30441436-C10FA476-503F-486A-91A6-716DEB431AB6Q31083435-B0D01F18-F4A1-413D-B4F4-D4DCD4366DE3Q33584872-DAE17F1A-21AB-4FDA-A0F3-B3ADD2D18212Q33788186-99B64D6B-F39E-4F52-A1A3-9E1F9DDBE6FFQ33858908-CBD1F7D7-4078-4755-AD0A-DA11F6EA3599Q34009585-90A1E83B-D3EA-419F-A4A9-8E47D0E9AF30Q34034242-1707290E-3601-466B-84A0-CD5DC8EC62E2Q35191220-8A0652D8-5509-42D3-9A77-8C2BCAF481CFQ35692346-67FE403E-89CA-478B-8E5E-E92AD06B267FQ36427185-2DB1ACD7-4ECE-42EC-9DBB-641D2FB57483Q37002887-70F67BE6-C59B-4C45-9FEC-C838AECFB605Q38185911-E9B8FD4C-402C-47DE-966C-7907E289DE1AQ41434206-569F68F8-EDF3-4859-B88A-DC774F6CA030Q54217815-501DF0A7-4039-4BCE-9434-C76140CCAE9F
P2860
Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@ast
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@en
type
label
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@ast
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@en
prefLabel
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@ast
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@en
P2093
P2860
P1476
Mucosal immunogenicity of a ho ...... he A2 domain of cholera toxin.
@en
P2093
P2860
P304
P407
P577
1998-02-01T00:00:00Z